| PP090102000680 |
Amgen Inc. |
Nplate™ |
romiplostim |
A thrombop.. |
Adult chro.. |
Marketed, Phase III |
View Details
|
| PP090811004969 |
Amgen Inc. (since Jan 2012), Micromet, Inc. |
BLINCYTO®, MT103 |
blinatumomab |
An anti-CD.. |
Acute Lymp.. |
Approved, Phase II, Phase II, Phase II |
View Details
|
| PP120207009055 |
Amgen Inc. |
Tezspire, AMG 157, MEDI9929 |
tezepelumab-ekko |
Inhibiting.. |
Severe ast.. |
Approved, Phase III, Phase III, Phase III, Phase II |
View Details
|
| PP130625011435 |
Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Co., Ltd. |
KHK4083, AMG 451 |
rocatinlimab |
An anti-OX.. |
Atopic der.. |
Phase III completed, Phase III, Phase II |
View Details
|
| PP150522013200 |
Amgen Inc. (since Apr 2021), Five Prime Therapeutics, Inc. |
FPA144 |
bemarituzumab |
An anti- f.. |
Gastric ca.. |
Phase III, Phase III |
View Details
|
| PP160403014059 |
Anavex Life Sciences Corp. |
ANAVEX2-73 |
blarcamesine |
To restore.. |
Alzheimer'.. |
NDA, Phase III, Phase III, Phase III, Phase III, Phase II |
View Details
|
| PP160403014061 |
Anavex Life Sciences Corp. |
ANAVEX3-71, AF710B |
|
A sigma-1 .. |
Frontotemp.. |
Phase III, Phase III, Phase II |
View Details
|
| PP160403014062 |
Anavex Life Sciences Corp. |
ANAVEX1-41 |
|
A sigma-1 .. |
Depression.. |
Preclinical, Preclinical |
View Details
|
| PP160524014205 |
Biogen Inc. (since Mar 2015), Biogen Idec |
BIIB059 |
litifilimab |
An anti-bl.. |
Systemic l.. |
Phase III, Phase III |
View Details
|
| PP160831014789 |
Sagimet Biosciences (since Aug 2019), 3-V Biosciences, Inc. |
TVB-2640, ASC40 |
denifanstat |
A selectiv.. |
Metabolic .. |
Phase II completed, Phase II, Phase II, Phase II, Phase III, Phase III completed |
View Details
|